Artículos de revistas sobre el tema "MEIS Inhibitors"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "MEIS Inhibitors".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Kocabas, F., S. N. Eren, M. Uslu y M. Y. Yuksel. "P69Identification of cardiogenic and hematopoietic MEIS Inhibitors". Cardiovascular Research 114, suppl_1 (1 de abril de 2018): S18—S19. http://dx.doi.org/10.1093/cvr/cvy060.033.
Texto completoGİRGİN, Birkan, Medine KARADAĞ-ALPASLAN y Fatih KOCABAŞ. "Oncogenic and tumor suppressor function of MEIS and associated factors". TURKISH JOURNAL OF BIOLOGY 44, n.º 6 (14 de diciembre de 2020): 328–55. http://dx.doi.org/10.3906/biy-2006-25.
Texto completoBarbosa, Karina, Anagha Deshpande, Ping Xiang, Bo-Rui Chen, Adam Brown, Neil Robertson, Younguk Sun et al. "High-Density Domain-Focused CRISPR Screens Reveal Epigenetic Regulators of Hox/Meis Gene Expression in Acute Myeloid Leukemia". Blood 136, Supplement 1 (5 de noviembre de 2020): 2–3. http://dx.doi.org/10.1182/blood-2020-141412.
Texto completoBisaillon, Richard, Eva Schmidt, Anne-Sophie Guenier y Guy Sauvageau. "Identification of MEIS-PBX inhibitors as potential anti-leukemic agents using a high-throughput bret-based assay". Experimental Hematology 41, n.º 8 (agosto de 2013): S51. http://dx.doi.org/10.1016/j.exphem.2013.05.201.
Texto completoCastellet, Helena, Guillermo Ramil López, Ana Garrido, Alícia Artigas-Baleri, Marta Pratcorona, Olga Salamero, Albert Cortés-Bullich et al. "Ubtf tandem Duplications Define a Novel Subtype of Acute Myeloid Leukemia Associated with Younger Age, WT1 Mutations and HOXA9 Marked Overexpression". Blood 142, Supplement 1 (28 de noviembre de 2023): 6045. http://dx.doi.org/10.1182/blood-2023-186064.
Texto completoBreitinger, Constanze, Emanuel Maethner, Maria-Paz Garcia-Cuellar, Alexandra Schambony, Kirsten Schilling, Klaus D. Fischer y Robert K. Slany. "Hox Genes Regulate Rac1 Activity Through Control of Vav2 expression". Blood 118, n.º 21 (18 de noviembre de 2011): 60. http://dx.doi.org/10.1182/blood.v118.21.60.60.
Texto completoJarocha, Danuta Jadwiga, Paul Gadue, Wei Tong, Robert C. Newton y Mortimer Poncz. "Janus Kinase (Jak) 1 Inhibition Affects Both Megakaryopoiesis and Thrombopoiesis". Blood 132, Supplement 1 (29 de noviembre de 2018): 2559. http://dx.doi.org/10.1182/blood-2018-99-115407.
Texto completoHaneline, Laura S., Khadijeh R. Bijangi-Vishehsaraei, Adam Werne, Kristina Wilson McKenzie, Susanna Davis, Hidenori Ichijo y Mohammad R. Saadatzadeh. "TNF-α Hypersensitivity of Fanconi Anemia Type C Deficient Cells Is Dependent on the Apoptosis Signal-Regulating Kinase 1 Signaling Pathway." Blood 104, n.º 11 (16 de noviembre de 2004): 724. http://dx.doi.org/10.1182/blood.v104.11.724.724.
Texto completoWang, Wei, Peng Li, Annette Schettino, Zhe Peng y Maureen McLeod. "Characterization of Functional Regions in the Schizosaccharomyces pombe mei3 Developmental Activator". Genetics 150, n.º 3 (1 de noviembre de 1998): 1007–18. http://dx.doi.org/10.1093/genetics/150.3.1007.
Texto completoKAYA, Mustafa Oğuzhan. "Out-of-mind Inhibitors Of Human Serum Paraoxonase 1 (PON1): An In Vitro study". Middle East Journal of Science 3, n.º 1 (26 de agosto de 2017): 59–77. http://dx.doi.org/10.23884/mejs.2017.3.1.07.
Texto completoAgarwal, Archana, Gregory Russell Pond, Catherine Curran, Amin Nassar, Pier Vitale Nuzzo, Vivek Kumar, Bradley Alexander McGregor et al. "Impact of concurrent medications on outcomes with PD1/PD-L1 inhibitors for metastatic urothelial carcinoma." Journal of Clinical Oncology 37, n.º 7_suppl (1 de marzo de 2019): 435. http://dx.doi.org/10.1200/jco.2019.37.7_suppl.435.
Texto completoAltman, Jessica K., Heather Glaser, Amanda Redig, Antonella Sassano, Martin S. Tallman y Leonidas C. Platanias. "Targeting the Mnk Pathway Enhances Chemotherapy-Induced Antileukemic Responses." Blood 112, n.º 11 (16 de noviembre de 2008): 1617. http://dx.doi.org/10.1182/blood.v112.11.1617.1617.
Texto completoWaters, Andrew Michael, Wen-Hsuan Chang, Clint Stalnecker, Cole Edwards, Runying Yang, Craig M. Goodwin, Adrienne D. Cox y Channing J. Der. "Abstract 1075: Identification of resistance mechanisms to direct KRAS inhibition in pancreatic cancer". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 1075. http://dx.doi.org/10.1158/1538-7445.am2023-1075.
Texto completoMattos, Daphne R., Xuemei Wan, Jeffrey D. Serrill, Minh H. Nguyen, Ian R. Humphreys, Benoit Viollet, Amos B. Smith, Kerry L. McPhail y Jane E. Ishmael. "The Marine-Derived Macrolactone Mandelalide A Is an Indirect Activator of AMPK". Marine Drugs 20, n.º 7 (27 de junio de 2022): 418. http://dx.doi.org/10.3390/md20070418.
Texto completoDelgado, Irene, Alejandra C. López-Delgado, Alberto Roselló-Díez, Giovanna Giovinazzo, Vanessa Cadenas, Laura Fernández-de-Manuel, Fátima Sánchez-Cabo, Matthew J. Anderson, Mark Lewandoski y Miguel Torres. "Proximo-distal positional information encoded by an Fgf-regulated gradient of homeodomain transcription factors in the vertebrate limb". Science Advances 6, n.º 23 (junio de 2020): eaaz0742. http://dx.doi.org/10.1126/sciadv.aaz0742.
Texto completoSchevzov, Galina, Anthony J. Kee, Bin Wang, Vanessa B. Sequeira, Jeff Hook, Jason D. Coombes, Christine A. Lucas et al. "Regulation of cell proliferation by ERK and signal-dependent nuclear translocation of ERK is dependent on Tm5NM1-containing actin filaments". Molecular Biology of the Cell 26, n.º 13 (julio de 2015): 2475–90. http://dx.doi.org/10.1091/mbc.e14-10-1453.
Texto completoIhlefeld, Katja, Ralf Frederik Claas, Alexander Koch, Josef M. Pfeilschifter y Dagmar Meyer zu Heringdorf. "Evidence for a link between histone deacetylation and Ca2+ homoeostasis in sphingosine-1-phosphate lyase-deficient fibroblasts". Biochemical Journal 447, n.º 3 (5 de octubre de 2012): 457–64. http://dx.doi.org/10.1042/bj20120811.
Texto completoHamaguchi, Yukiyoshi, Steven K. Juhn y Yasuo Sakakura. "Protease Inhibitors in Middle Ear Effusions from Experimental Otitis Media with Effusion: Kinetics of α1-Antitrypsin and α2-Macroglobulin Levels". Annals of Otology, Rhinology & Laryngology 98, n.º 4 (abril de 1989): 287–92. http://dx.doi.org/10.1177/000348948909800410.
Texto completoKundu, Mondira, Chia-Ying Yang, Kelly McCastlain, Junmin Wu, Ji Zhang, Tullia Lindsten, Paul Ney y Craig B. Thompson. "Hsp90 regulates Ulk1-mediated autophagic clearance of mitochondria". Blood 112, n.º 11 (16 de noviembre de 2008): 3458. http://dx.doi.org/10.1182/blood.v112.11.3458.3458.
Texto completoWeddle, Carly y Paul Burridge. "Abstract A070: Examining patient-specific responses to PARP inhibitors in a novel, human induced pluripotent stem cell-based model of breast cancer". Cancer Research 84, n.º 3_Supplement_1 (1 de febrero de 2024): A070. http://dx.doi.org/10.1158/1538-7445.advbc23-a070.
Texto completoYu, Lanlan, Baohui Wang, Xurui Sun y Jian Song. "Synthesis and properties of a MEAS quadripolymer scale inhibitor". Desalination and Water Treatment 52, n.º 10-12 (16 de mayo de 2013): 1865–71. http://dx.doi.org/10.1080/19443994.2013.792014.
Texto completoRenaldo, Kyle, Shelby Sloan, JiHyun Chung, Lindsay Courtney, Konstantin Shilo, William Kisseberth y Robert A. Baiocchi. "Exploring PRMT5 As a Potential Therapeutic Target in Canine Lymphomas". Blood 132, Supplement 1 (29 de noviembre de 2018): 4182. http://dx.doi.org/10.1182/blood-2018-99-119115.
Texto completoAlexander, D. L., L. G. Ganem, P. Fernandez-Salguero, F. Gonzalez y C. R. Jefcoate. "Aryl-hydrocarbon receptor is an inhibitory regulator of lipid synthesis and of commitment to adipogenesis". Journal of Cell Science 111, n.º 22 (15 de noviembre de 1998): 3311–22. http://dx.doi.org/10.1242/jcs.111.22.3311.
Texto completoLambert, Michele P., Yuhuan Wang, M. Anna Kowalska y Mortimer Poncz. "Negative Paracrine Effect of Platelet Factor 4 on Megakaryopoiesis Occurs through Lipoprotein Related Protein Receptor-1 on Megakaryocytes." Blood 110, n.º 11 (16 de noviembre de 2007): 97. http://dx.doi.org/10.1182/blood.v110.11.97.97.
Texto completoKhan, Husain Yar, Sahar Bannoura, Hirva Mamdani, Amro Aboukameel, Yousef Mzannar, Yiwei Li, Mohammad Najeeb Al-Hallak et al. "Abstract 5315: Anti-tumor activity of KRASG12C inhibitors is enhanced when combined with Cdc42 effector p21-activated kinase 4 targeting agents". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 5315. http://dx.doi.org/10.1158/1538-7445.am2022-5315.
Texto completoNigam, Aradhya, Walid K. Chatila, Gnana P. Krishnamoorthy, Alan L. Ho, James A. Fagin, Nikolaus D. Schultz y Brian R. Untch. "Abstract 1181: PTEN loss-of-function mutations prevalent in HRAS-mutant cancers results in resistance to targeted therapy". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 1181. http://dx.doi.org/10.1158/1538-7445.am2022-1181.
Texto completoZhou, Yang, Sahar Alimohamadi, Li Wang, Ziqing Liu, Joseph B. Wall, Chaoying Yin, Jiandong Liu y Li Qian. "A Loss of Function Screen of Epigenetic Modifiers and Splicing Factors during Early Stage of Cardiac Reprogramming". Stem Cells International 2018 (2018): 1–14. http://dx.doi.org/10.1155/2018/3814747.
Texto completoTanajura, Luiz, Áurea Chaves, Andrea Abizaid y José Costa Júnior. "Monotherapy with P2Y12 receptor inhibitors in patients treated by percutaneous coronary intervention". Journal of Transcatheter Interventions 29 (2 de diciembre de 2021): 1–9. http://dx.doi.org/10.31160/jotci202129a202106.
Texto completoDinchuk, Joseph E., Carolyn Cao, Fei Huang, Karen A. Reeves, Jeanne Wang, Fanny Myers, Glenn H. Cantor et al. "Insulin Receptor (IR) Pathway Hyperactivity in IGF-IR Null Cells and Suppression of Downstream Growth Signaling Using the Dual IGF-IR/IR Inhibitor, BMS-754807". Endocrinology 151, n.º 9 (7 de julio de 2010): 4123–32. http://dx.doi.org/10.1210/en.2010-0032.
Texto completoHamaguchi, Yukiyoshi, Yuichi Majima, Kenji Sakakura y Yasuo Sakakura. "Lysosomal Thiol Proteases in Middle Ear Effusions". Annals of Otology, Rhinology & Laryngology 95, n.º 3_suppl (mayo de 1986): 9–12. http://dx.doi.org/10.1177/00034894860950s303.
Texto completoDizaye, Kawa F. y Asmaa A. Ahmed. "Renoprotective Evaluations of Different Angiotensin Inhibitors on Diabetic Nephropathy in Rats". Middle East Journal of Internal Medicine 9, n.º 3 (noviembre de 2016): 3–11. http://dx.doi.org/10.5742/meim.2016.92897.
Texto completoMack, Fiona A., Jagruti H. Patel, Mangatt P. Biju, Volker H. Haase y M. Celeste Simon. "Decreased Growth of Vhl−/− Fibrosarcomas Is Associated with Elevated Levels of Cyclin Kinase Inhibitors p21 and p27". Molecular and Cellular Biology 25, n.º 11 (1 de junio de 2005): 4565–78. http://dx.doi.org/10.1128/mcb.25.11.4565-4578.2005.
Texto completoShim, Sungbo, Yujin Kim, Jongdae Shin, Jieun Kim y Soochul Park. "Regulation of EphA8 Gene Expression by TALE Homeobox Transcription Factors during Development of the Mesencephalon". Molecular and Cellular Biology 27, n.º 5 (18 de diciembre de 2006): 1614–30. http://dx.doi.org/10.1128/mcb.01429-06.
Texto completoSun, Jun, Juan Kong, Yingli Duan, Frances L. Szeto, Anne Liao, James L. Madara y Yan Chun Li. "Increased NF-κB activity in fibroblasts lacking the vitamin D receptor". American Journal of Physiology-Endocrinology and Metabolism 291, n.º 2 (agosto de 2006): E315—E322. http://dx.doi.org/10.1152/ajpendo.00590.2005.
Texto completoYerlikaya, Azmi, Scot R. Kimball y Bruce A. Stanley. "Phosphorylation of eIF2α in response to 26S proteasome inhibition is mediated by the haem-regulated inhibitor (HRI) kinase". Biochemical Journal 412, n.º 3 (28 de mayo de 2008): 579–88. http://dx.doi.org/10.1042/bj20080324.
Texto completoSaadatzadeh, M. Reza, Khadijeh Bijangi-Vishehsaraei y Laura S. Haneline. "The Role of Stress Activated Protein Kinases in Promoting Fanconi Anemia Hematopoietic Stem and Progenitor Cell Dysfunction". Blood 112, n.º 11 (16 de noviembre de 2008): 1043. http://dx.doi.org/10.1182/blood.v112.11.1043.1043.
Texto completoIshida, Yoji, Syugo Kowata, Kazunori Murai, Tatsuo Oyake y Shigeki Ito. "TAT/HDL Induces the Phospholylation of Cofilin in the Process of Platelet Production of Megakaryocytes." Blood 104, n.º 11 (16 de noviembre de 2004): 2186. http://dx.doi.org/10.1182/blood.v104.11.2186.2186.
Texto completoSealover, Nancy, Bridget Finniff y Robert Kortum. "Abstract B033: Wild-type RAS signaling is an essential therapeutic target in RAS-mutated cancers". Molecular Cancer Research 21, n.º 5_Supplement (1 de mayo de 2023): B033. http://dx.doi.org/10.1158/1557-3125.ras23-b033.
Texto completoRubin, Elina, Agnese C. Pippione, Matthew Boyko, Giacomo Einaudi, Stefano Sainas, Massimo Collino, Carlo Cifani et al. "A New NF-κB Inhibitor, MEDS-23, Reduces the Severity of Adverse Post-Ischemic Stroke Outcomes in Rats". Brain Sciences 12, n.º 1 (28 de diciembre de 2021): 35. http://dx.doi.org/10.3390/brainsci12010035.
Texto completoGRILL, Constance, Ferdous GHEYAS, Priya DAYANANTH, Weihong JIN, Wei DING, Ping QIU, Luquan WANG, Ronald J. DOLL y Jessie M. ENGLISH. "Analysis of the ERK1,2 transcriptome in mammary epithelial cells". Biochemical Journal 381, n.º 3 (27 de julio de 2004): 635–44. http://dx.doi.org/10.1042/bj20031688.
Texto completoTergaonkar, Vinay, Virginie Bottero, Masahito Ikawa, Qiutang Li y Inder M. Verma. "IκB Kinase-Independent IκBα Degradation Pathway: Functional NF-κB Activity and Implications for Cancer Therapy". Molecular and Cellular Biology 23, n.º 22 (15 de noviembre de 2003): 8070–83. http://dx.doi.org/10.1128/mcb.23.22.8070-8083.2003.
Texto completoTanajura, Luiz, Áurea Chaves, Rafaela Freitas, Ana Barbosa, Kelvyn Vital y José Delamain. "Aspirin versus P2Y12 inhibitors for secondary prevention after percutaneous coronary intervention". Journal of Transcatheter Interventions 31 (14 de diciembre de 2023): 1–7. http://dx.doi.org/10.31160/jotci202331a202304.
Texto completoVanzyl, Erin J., Hadil Sayed, Alex B. Blackmore, Kayleigh R. C. Rick, Pasan Fernando y Bruce C. McKay. "The spliceosome inhibitors isoginkgetin and pladienolide B induce ATF3-dependent cell death". PLOS ONE 15, n.º 12 (28 de diciembre de 2020): e0224953. http://dx.doi.org/10.1371/journal.pone.0224953.
Texto completoMukherjee, Kaustav, Bruce Futcher y Janet Leatherwood. "mmi1 and rep2 mRNAs are novel RNA targets of the Mei2 RNA-binding protein during early meiosis in Schizosaccharomyces pombe". Open Biology 8, n.º 9 (septiembre de 2018): 180110. http://dx.doi.org/10.1098/rsob.180110.
Texto completoGreene, Teshell K., Li Zhai, Beatrice Razzo, Karen Vo, Denise E. Sabatino, Rodney M. Camire, Valder R. Arruda y Mortimer Poncz. "Platelet Factor VIII-Induced Megakaryocyte Apoptosis: Implications for Hemophilia A Gene Therapy". Blood 120, n.º 21 (16 de noviembre de 2012): 2051. http://dx.doi.org/10.1182/blood.v120.21.2051.2051.
Texto completoKariya, Shin, Mitsuhiro Okano, Katsuya Aoji, Michiya Kosaka, Emiko Chikumoto, Hisashi Hattori, Koji Yuen, Shinji Nishioka, Keiko Nishioka y Kazunori Nishizaki. "Role of Macrophage Migration Inhibitory Factor in Otitis Media with Effusion in Adults". Clinical Diagnostic Laboratory Immunology 10, n.º 3 (mayo de 2003): 417–22. http://dx.doi.org/10.1128/cdli.10.3.417-422.2003.
Texto completoÇAKMAK, Reşit, Ercan ÇINAR, Eyüp BAŞARAN y Mehmet BOĞA. "SYNTHESIS, CHARACTERIZATION AND BIOLOGICAL EVALUATION OF ESTER DERIVATIVES OF 4-(DIETHYLAMINO)SALICYLALDEHYDE AS CHOLINESTERASE, AND TYROSINASE INHIBITORS". Middle East Journal of Science 7, n.º 2 (30 de diciembre de 2021): 137–44. http://dx.doi.org/10.51477/mejs.947973.
Texto completoLuciana, Luciana, Firdha Senja Maelaningsih y Diah Permata Sari. "PENGGUNAAN PROTON PUMP INHIBITOR PADA PASIEN RAWAT JALAN DI RSIA DHIA CIPUTAT TANGERANG SELATAN". Edu Masda Journal 6, n.º 1 (18 de abril de 2022): 36. http://dx.doi.org/10.52118/edumasda.v6i1.151.
Texto completoSealover, Nancy E. y Robert L. Kortum. "Abstract 413: WT RAS signaling is an essential therapeutic target in RAS mutated cancers". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 413. http://dx.doi.org/10.1158/1538-7445.am2022-413.
Texto completoMinami, Kahori, Yukihiro Tambe, Ryosuke Watanabe, Takahiro Isono, Masataka Haneda, Ken-ichi Isobe, Toshiyuki Kobayashi et al. "Suppression of Viral Replication by Stress-Inducible GADD34 Protein via the Mammalian Serine/Threonine Protein Kinase mTOR Pathway". Journal of Virology 81, n.º 20 (1 de agosto de 2007): 11106–15. http://dx.doi.org/10.1128/jvi.01063-07.
Texto completo